John Sledge Custom Cabinets

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Human Growth Hormone Injections in the Knee Joint to Treat Osteoarthritis

Phase 2

Suspended

Conditions: Osteoarthritis, Knee

Interventions: Drug: Recombinant human growth hormone

First Posted Date: 2024-04-09

Last Posted Date: 2024-10-04

Lead Sponsor: John Sledge

Target Recruit Count: 23

Registration Number: NCT06354023

Locations: 🇺🇸
BioShift Life Sciences, Santa Monica, California, United States

Prev
1
Next

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy